Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 170 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Tripartite motif-containing protein 21 is involved in IFN-γ-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors.
Won J, Kang HS, Kim NY, Dezhbord M, Marakkalage KG, Lee E-H, Lee D, Park S, Kim D-S, Kim K-H
J Virol, 98(6):e0046824, 23 May 2024
Cited by: 0 articles | PMID: 38780244 | PMCID: PMC11237615
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Mathematical Models of Early Hepatitis B Virus Dynamics in Humanized Mice.
Ciupe SM, Dahari H, Ploss A
Bull Math Biol, 86(5):53, 09 Apr 2024
Cited by: 2 articles | PMID: 38594319 | PMCID: PMC11003933
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
IFN-γ: A Crucial Player in the Fight Against HBV Infection?
Hillaire MLB, Lawrence P, Lagrange B
Immune Netw, 23(4):e30, 15 Jun 2023
Cited by: 4 articles | PMID: 37670813 | PMCID: PMC10475827
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Hepatitis B Virus Reactivation and Mycobacterial Infections Associated With Ustekinumab: A Retrospective Study of an International Pharmacovigilance Database.
Wang J, Geng X, Zhang X, Xiao Y, Wang W
Front Pharmacol, 13:921084, 04 Jul 2022
Cited by: 0 articles | PMID: 35860015 | PMCID: PMC9289361
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse.
Tseng TN, Kuo YH, Hu TH, Hung CH, Wang JH, Lu SN, Chen CH
Viruses, 14(6):1189, 30 May 2022
Cited by: 1 article | PMID: 35746660 | PMCID: PMC9227936
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B.
Choi WM, Kim GA, Choi J, Han S, Lim YS
J Clin Invest, 132(10):e154833, 01 May 2022
Cited by: 15 articles | PMID: 35358094 | PMCID: PMC9106348
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro.
Michelet M, Alfaiate D, Chardès B, Pons C, Faure-Dupuy S, Engleitner T, Farhat R, Riedl T, Legrand AF, Rad R, Rivoire M, Zoulim F, Heikenwälder M, Salvetti A, Durantel D, Lucifora J
JHEP Rep, 4(3):100415, 14 Dec 2021
Cited by: 2 articles | PMID: 35141510 | PMCID: PMC8792426
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application.
Du Y, Broering R, Li X, Zhang X, Liu J, Yang D, Lu M
Front Immunol, 12:766534, 29 Oct 2021
Cited by: 21 articles | PMID: 34777385 | PMCID: PMC8586444
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Interferon and Hepatitis B: Current and Future Perspectives.
Ye J, Chen J
Front Immunol, 12:733364, 07 Sep 2021
Cited by: 51 articles | PMID: 34557195 | PMCID: PMC8452902
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunobiology and pathogenesis of hepatitis B virus infection.
Iannacone M, Guidotti LG
Nat Rev Immunol, 22(1):19-32, 17 May 2021
Cited by: 162 articles | PMID: 34002067
Add to export list Review
Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics.
Akiyama S, Cotter TG, Sakuraba A
World J Gastroenterol, 27(19):2312-2324, 01 May 2021
Cited by: 8 articles | PMID: 34040324 | PMCID: PMC8130042
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases.
Gálvez NMS, Bohmwald K, Pacheco GA, Andrade CA, Carreño LJ, Kalergis AM
Clin Microbiol Rev, 34(2):e00232-20, 23 Dec 2020
Cited by: 18 articles | PMID: 33361143 | PMCID: PMC7950362
Add to export list Review Free full text in Europe PMC
Role of alcohol in pathogenesis of hepatitis B virus infection.
Ganesan M, Eikenberry A, Poluektova LY, Kharbanda KK, Osna NA
World J Gastroenterol, 26(9):883-903, 01 Mar 2020
Cited by: 19 articles | PMID: 32206001 | PMCID: PMC7081008
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Hepatitis B: Current Status of Therapy and Future Therapies.
Spyrou E, Smith CI, Ghany MG
Gastroenterol Clin North Am, 49(2):215-238, 29 Mar 2020
Cited by: 22 articles | PMID: 32389360 | PMCID: PMC7444867
Add to export list Review Free full text in Europe PMC
Lack of T-cell-mediated IL-2 and TNFα production is linked to decreased CD58 expression in intestinal tissue during acute simian immunodeficiency virus infection.
Pan D, Das A, Srivastav SK, Traina-Dorge V, Didier PJ, Pahar B
J Gen Virol, 100(1):26-34, 29 Nov 2018
Cited by: 4 articles | PMID: 30480508 | PMCID: PMC6537620
Add to export list Free full text in Europe PMC
In Vivo Model Systems for Hepatitis B Virus Research.
Ortega-Prieto AM, Cherry C, Gunn H, Dorner M
ACS Infect Dis, 5(5):688-702, 08 Jan 2019
Cited by: 18 articles | PMID: 30539633 | PMCID: PMC6515358
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Modeling the dynamics of hepatitis B infection, immunity, and drug therapy.
Ciupe SM
Immunol Rev, 285(1):38-54, 01 Sep 2018
Cited by: 16 articles | PMID: 30129194
Add to export list Review
Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.
Hu J, Lin YY, Chen PJ, Watashi K, Wakita T
Gastroenterology, 156(2):338-354, 19 Sep 2018
Cited by: 56 articles | PMID: 30243619 | PMCID: PMC6649672
Add to export list Review Free full text in Europe PMC
Immunotherapy for Chronic Hepatitis B Virus Infection.
Bertoletti A, Le Bert N
Gut Liver, 12(5):497-507, 01 Sep 2018
Cited by: 57 articles | PMID: 29316747 | PMCID: PMC6143456
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus.
Kim DH, Park ES, Lee AR, Park S, Park YK, Ahn SH, Kang HS, Won JH, Ha YN, Jae B, Kim DS, Chung WC, Song MJ, Kim KH, Park SH, Kim SH, Kim KH
Nat Commun, 9(1):3284, 16 Aug 2018
Cited by: 28 articles | PMID: 30115930 | PMCID: PMC6095909
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ideal Cure for Hepatitis B Infection: The Target is in Sight.
Anikhindi SA, Kumar A, Kumar A, Sharma P, Singla V, Bansal N, Arora A
J Clin Exp Hepatol, 8(2):188-194, 07 Nov 2017
Cited by: 3 articles | PMID: 29892183 | PMCID: PMC5992304
Add to export list Review Free full text in Europe PMC
Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
Ma Z, Cao Q, Xiong Y, Zhang E, Lu M
Vaccines (Basel), 6(1):E6, 16 Jan 2018
Cited by: 39 articles | PMID: 29337856 | PMCID: PMC5874647
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
Lebossé F, Testoni B, Fresquet J, Facchetti F, Galmozzi E, Fournier M, Hervieu V, Berthillon P, Berby F, Bordes I, Durantel D, Levrero M, Lampertico P, Zoulim F
J Hepatol, 66(5):897-909, 30 Dec 2016
Cited by: 67 articles | PMID: 28043874
Add to export list
Activating the innate immune response to counter chronic hepatitis B virus infection.
Lamb C, Arbuthnot P
Expert Opin Biol Ther, 16(12):1517-1527, 20 Sep 2016
Cited by: 5 articles | PMID: 27603796
Add to export list Review
Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection.
Kouwaki T, Fukushima Y, Daito T, Sanada T, Yamamoto N, Mifsud EJ, Leong CR, Tsukiyama-Kohara K, Kohara M, Matsumoto M, Seya T, Oshiumi H
Front Immunol, 7:335, 31 Aug 2016
Cited by: 105 articles | PMID: 27630638 | PMCID: PMC5005343
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 170 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Tripartite motif-containing protein 21 is involved in IFN-γ-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors.

Mathematical Models of Early Hepatitis B Virus Dynamics in Humanized Mice.

IFN-γ: A Crucial Player in the Fight Against HBV Infection?

Hepatitis B Virus Reactivation and Mycobacterial Infections Associated With Ustekinumab: A Retrospective Study of an International Pharmacovigilance Database.

Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse.

Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B.

Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro.

In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application.

Interferon and Hepatitis B: Current and Future Perspectives.

Immunobiology and pathogenesis of hepatitis B virus infection.

Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics.

Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases.

Role of alcohol in pathogenesis of hepatitis B virus infection.

Hepatitis B: Current Status of Therapy and Future Therapies.

Lack of T-cell-mediated IL-2 and TNFα production is linked to decreased CD58 expression in intestinal tissue during acute simian immunodeficiency virus infection.

In Vivo Model Systems for Hepatitis B Virus Research.

Modeling the dynamics of hepatitis B infection, immunity, and drug therapy.

Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.

Immunotherapy for Chronic Hepatitis B Virus Infection.

Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus.

Ideal Cure for Hepatitis B Infection: The Target is in Sight.

Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.

Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.

Activating the innate immune response to counter chronic hepatitis B virus infection.

Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection.

Partnerships & funding